After it was demonstrated that LGR5+ cells have the capacity to promote gastric carcinogenesis upon mutation of Kras (16), other studies, including a recent one using Gpr30 as a chief cell marker, concluded that chief cells are unlikely to give rise to metaplasia and cancer lesions (31). The gene discussed is LGR5; the disease is cancer.